Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of ANB033

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-520409-38-00

Acronym

ANB033-101

Enrollment

Registered

2025-07-24

Start date

2025-11-14

Completion date

Unknown

Last updated

2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Celiac disease

None listed

Sex/Gender

All

Age

18 Years to No maximum

Finland, Germany, Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026